<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended SEPTEMBER 30, 1996
------------------
or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________
Commission File Number: 0-19271
-------
IDEXX LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 01-0393723
(State of incorporation) (I.R.S. EmployerIdentification No.)
ONE IDEXX DRIVE, WESTBROOK, MAINE 04092
(Address of principal executive offices) (Zip Code)
(207) 856-0300
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
As of October 31, 1996, 37,639,538 shares of the registrant's Common Stock, $.10
par value, were outstanding.
<PAGE> 2
IDEXX LABORATORIES, INC. AND SUBSIDIARIES
INDEX
Page
PART II -- OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K 3
SIGNATURES 4
2
<PAGE> 3
PART II - OTHER INFORMATION
Item 6. -- Other Statements
----------------
(a) Exhibits Page
----
27. Financial Data Schedule for Quarterly Report
on Form 10-Q for third quarter 1996. 5 - 7
(b) Reports on Form 8-K
The Company filed no reports on Form 8-K during the fiscal
quarter for which this report is filed.
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IDEXX LABORATORIES, INC.
Date: March 26, 1997
/s/ Merilee Raines
------------------------------------
Merilee Raines, Vice President of Finance
(Principal Accounting Officer)
4
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE IDEXX
LABORATORIES, INC. UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR
THE THIRD QUARTER ENDING SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<CIK> 0000874716
<NAME> IDEXX LABORATORIES, INC.
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> SEP-30-1996
<EXCHANGE-RATE> 1
<CASH> 125,473,257
<SECURITIES> 44,663,633
<RECEIVABLES> 66,713,469
<ALLOWANCES> 3,542,000
<INVENTORY> 41,034,066
<CURRENT-ASSETS> 285,771,945
<PP&E> 56,358,171
<DEPRECIATION> 20,741,193
<TOTAL-ASSETS> 356,634,132
<CURRENT-LIABILITIES> 47,551,614
<BONDS> 0
0
0
<COMMON> 3,761,114
<OTHER-SE> 305,321,404
<TOTAL-LIABILITY-AND-EQUITY> 356,634,132
<SALES> 193,112,515
<TOTAL-REVENUES> 193,112,515
<CGS> 82,448,687
<TOTAL-COSTS> 82,448,687
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 219,500
<INCOME-PRETAX> 39,668,100
<INCOME-TAX> 16,263,921
<INCOME-CONTINUING> 23,404,179
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 23,404,179
<EPS-PRIMARY> .59
<EPS-DILUTED> .59
</TABLE>
